US Stock MarketDetailed Quotes
JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Watchlist
0.1200
0.00000.00% Close 06/08 16:00 ET
0.1587High0.1110Low1.26KVolume
0.1318Open0.1200Pre Close161.00Turnover0.00%Turnover Ratio0.00P/E (TTM)0Market Cap0.253452wk High0.00P/E (Static)0Shares0.016052wk Low0.00P/B0Float Cap2.2400Historical High--Dividend TTM0Shs Float0.0160Historical Low--Div YieldTTM39.75%Amplitude0.1270Avg Price1Lot Size
Quarterly+Annual
YOY

(Q1)2023/03/31 | (FY)2022/12/31 | (Q4)2022/12/31 | (Q3)2022/09/30 | (Q2)2022/06/30 | (Q1)2022/03/31 | (FY)2021/12/31 | (Q4)2021/12/31 | (Q3)2021/09/30 | (Q2)2021/06/30 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Cost of revenue | ||||||||||
Gross profit | ||||||||||
Operating expense | 9.15%13.95M | 38.99%51.2M | 13.78%13.75M | 26.08%12.71M | 42.11%11.96M | 104.32%12.78M | 78.08%36.83M | 102.79%12.08M | 67.76%10.08M | 8.42M |
Selling and administrative expenses | -9.76%4.14M | 45.19%16.57M | 30.36%4.47M | 27.50%3.69M | 17.35%3.83M | 150.27%4.59M | 137.75%11.41M | 161.25%3.43M | 94.29%2.89M | --3.26M |
-General and administrative expense | -9.76%4.14M | 45.19%16.57M | 30.36%4.47M | 27.50%3.69M | 17.35%3.83M | 150.27%4.59M | 137.75%11.41M | 161.25%3.43M | 94.29%2.89M | --3.26M |
Research and development costs | 19.75%9.81M | 36.21%34.63M | 7.22%9.28M | 25.51%9.02M | 57.78%8.14M | 85.25%8.19M | 60.05%25.42M | 86.29%8.66M | 59.03%7.19M | --5.16M |
Operating profit | -9.15%-13.95M | -38.99%-51.2M | -13.78%-13.75M | -26.08%-12.71M | -42.11%-11.96M | -104.32%-12.78M | -78.08%-36.83M | -102.79%-12.08M | -67.76%-10.08M | -8.42M |
Net non-operating interest income expense | 54,700.00%1.1M | 3,077.78%268K | 2K | 91.89%-9K | ||||||
Non-operating interest income | 54,700.00%1.1M | ---- | ---- | --268K | ---- | --2K | ---- | ---- | ---- | ---- |
Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.89%9K | ---- |
Other net income (expense) | -113.33%-1.41M | 118.06%13.51M | -72.82%821K | -91.36%577K | 38,875.00%1.56M | 401.97%10.57M | 156.40%6.2M | 173.29%3.02M | 241.86%6.68M | 4K |
Gain on sale of security | -109.50%-575K | 339.92%7.2M | 200.00%150K | -65.56%155K | --845K | 272.81%6.05M | 72.40%-3M | 101.25%50K | 109.56%450K | ---- |
Special income (charges) | -116.63%-764K | -38.29%5.73M | -97.21%85K | -93.22%422K | --625K | --4.59M | --9.28M | --3.05M | --6.23M | --0 |
-Less:Restructuring and merger&acquisition | 116.63%764K | 38.29%-5.73M | 97.21%-85K | 93.22%-422K | ---625K | ---4.59M | ---9.28M | ---3.05M | ---6.23M | --0 |
Other non- operating income (expenses) | 5.41%-70K | 832.50%586K | ---- | ---- | 2,125.00%89K | -7,500.00%-74K | 27.93%-80K | ---- | ---- | --4K |
Income before tax | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | 68.48%-3.41M | -8.41M |
Income tax | ||||||||||
Net income | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | 68.48%-3.41M | -8.41M |
Net income continuous Operations | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | 68.48%-3.41M | ---8.41M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | 68.48%-3.41M | -8.41M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -546.13%-14.26M | -23.00%-37.69M | -45.87%-13.21M | -247.68%-11.86M | -23.65%-10.4M | 77.37%-2.21M | 3.26%-30.64M | 9.31%-9.06M | 68.48%-3.41M | -8.41M |
Basic earnings per share | ||||||||||
Diluted earnings per share | ||||||||||
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |